Mehabe score: 2 G Factor: 6 Piotski Score: 4 The stock has a rating OBSERVE & HOLD. The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 6 and Piotski score of 4.
Description
Integrated Capital Services engages in offering corporate advisory and consulting, expert services in Turnaround & Restructuring, Business Combinations, Takeovers, Mergers & Amalgamations.Site:539149Main Symbol:ICSL
Stock trades at 4.29, above its 50dma 3.12. It also trades above its 200dma 2.42. The stock remains bullish on techicals
The 52 week high is at 4.09 and the 52week low is at 1.00
Price Chart
P/E Chart
Sales and Margin
Strengths
– has delivered good profit growth of 53.78% CAGR over last 5 years
Weakness
– Stock is trading at 2.64 times its book value
-The company has delivered a poor sales growth of -21.42% over past five years.
-Earnings include an other income of Rs.5.43 Cr.
Competition
– The industry trades at a mean P/E of 26.0x. Jubilant Ingrevia trades at the industry’s max P/E of 141.55x. 539149 trades at a P/E of 2.96x
– Industry’s mean G-Factor is 4.4 while the mean Piotski score is 9.0. 539149 has a G-Factor of 6 and Piotski scoreof 4.
– Average 1 month return for industry is 6.0%. The max 1- month return was given by Integ. Capital: a return of 37.94 %
Quarterly Results
Sales for period ended Jun 2021 is Rs 0.15 cr compared to Rs 0.08 cr for period ended Jun 2020, a rise of 87.5%
Company reported negative operating profit of Rs -0.12 cr for period ended Jun 2021. For same period last year, operating profit was -0.03
The EPS for Jun 2021 was Rs -0.03 compared to Rs 0.23 for previous quarter ended Mar 2021 and Rs -0.03 for Jun 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 0.72 cr for period ended TTM vis-vis sales of Rs 0.65 cr for the period ended Mar 2021, a growth of 9.7%. The 3 year sales cagr stood at -23.0%.
Operating margins shrank to -27.78% for period ended TTM vis-vis -16.92% for period ended Mar 2021, contraction of 1086.0 bps.
Net Profit reported at Rs 5.17 cr for period ended TTM vis-vis sales of Rs 5.16 cr for the period ended Mar 2021, rising 0%.
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 79.0% compared to 17.0% over the last 3 Years. – The stock has given a return of 132% on a 1 Year basis vis-vis a return of 1% over the last 3 Years. – The compounded sales growth on a TTM bassis is -29% vis-vis a compounded sales growth of -36% over the last 3 Years. – The compounded profit growth on a TTM basis is 3325% vis-vis a compounded profit growth of 118% over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has remained largely constant. The Mar 2021 public holding stood at 25.04% vis-vis 25.04% for Dec 2020
Conclusion
– has delivered good profit growth of 53.78% CAGR over last 5 years – Stock is trading at 2.64 times its book value
-The company has delivered a poor sales growth of -21.42% over past five years.
-Earnings include an other income of Rs.5.43 Cr.
Fundamentally, the stock remains weak on business fundamentals. Weak near term results have dampened and questioned business drivers. We suggest to wait for a upturn in business performance.
Technically, the stock trades above its 50 DMA 3.12 and is trading at 4.29 It has shown near term bullish momentum contrary to business fundamentals. We suggest to observe price action. However as investors, who like to avoid timing the markets, we suggest to avoid the stock
